HL-A antigens and diabetes mellitus.
D000293:Adolescent; D000328:Adult; D001327:Autoimmune Diseases; D002464:Cell Migration Inhibition; D003601:Cytotoxicity Tests, Immunologic; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000188:drug therapy / Q000209:etiology / Q000235:genetics / Q000276:immunology*; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy / Q000209:etiology / Q000235:genetics / Q000276:immunology; D006649:Histocompatibility Antigens / Q000302:isolation & purification*; D006801:Humans; D007111:Immunity, Cellular; D007328:Insulin / Q000627:therapeutic use; D008875:Middle Aged; D009765:Obesity / Q000150:complications; D010179:Pancreas / Q000276:immunology; D010641:Phenotype
D006649:Histocompatibility Antigens; D007328:Insulin